Smith & Nephew plc (LON:SN) had its price objective boosted by J P Morgan Chase & Co from GBX 1,280 ($16.62) to GBX 1,361 ($17.67) in a report released on Monday, July 31st. The firm currently has a neutral rating on the stock.
Several other research analysts have also recently weighed in on the stock. Deutsche Bank AG restated a hold rating and issued a GBX 1,200 ($15.58) price objective on shares of Smith & Nephew plc in a research report on Friday, July 28th. Goldman Sachs Group, Inc. (The) restated a neutral rating and issued a GBX 1,270 ($16.49) price objective on shares of Smith & Nephew plc in a research report on Friday, May 5th. Credit Suisse Group restated a neutral rating and issued a GBX 1,200 ($15.58) price objective on shares of Smith & Nephew plc in a research report on Thursday, July 20th. Jefferies Group LLC upped their target price on shares of Smith & Nephew plc from GBX 1,350 ($17.53) to GBX 1,515 ($19.67) and gave the company a buy rating in a research report on Friday, July 28th. Finally, HSBC Holdings plc reiterated a hold rating and set a GBX 1,320 ($17.14) target price on shares of Smith & Nephew plc in a research report on Monday, July 10th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. The company has an average rating of Hold and a consensus target price of GBX 1,289.25 ($16.74).
Smith & Nephew plc (SN) opened at 1368.00 on Monday. Smith & Nephew plc has a 12 month low of GBX 1,064.91 and a 12 month high of GBX 1,389.33. The stock’s market cap is GBX 11.98 billion. The stock’s 50 day moving average price is GBX 1,327.76 and its 200-day moving average price is GBX 1,285.50.
The firm also recently disclosed a dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Thursday, October 5th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a dividend yield of 0.72%.
In other Smith & Nephew plc news, insider Virginia Bottomley acquired 223 shares of Smith & Nephew plc stock in a transaction dated Wednesday, August 16th. The stock was bought at an average cost of GBX 1,380 ($17.92) per share, for a total transaction of £3,077.40 ($3,995.07).
About Smith & Nephew plc
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
What are top analysts saying about Smith & Nephew plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Smith & Nephew plc and related companies.